Literature DB >> 8997322

Firing properties of identified parasympathetic cardiac neurons in nucleus ambiguus.

D Mendelowitz1.   

Abstract

This study tests the hypothesis that identified parasympathetic cardiac neurons in the nucleus ambiguus possess pacemaker-like activity or, alternatively, that these neurons are inherently silent. To test this hypothesis and to examine the firing properties of these neurons, parasympathetic cardiac neurons were identified by the presence of a fluorescent tracer previously applied to their terminals surrounding the heart. Perforated patch-clamp electrophysiological techniques were used to study the spontaneous and depolarization-evoked firing patterns of these identified parasympathetic cardiac neurons in an in vitro brain stem slice. Parasympathetic cardiac neurons were silent. On injection of depolarizing current, however, these neurons fired with both little delay and spike frequency adaptation. Hyperpolarizing prepulses elicited a significant delay before depolarization-evoked firing The Ca(2+)-activated K+ channel blocker apamin, but not charybdotoxin, increased the depolarization-activated firing frequency of these neurons and inhibited the afterhyperpolarization. In summary, parasympathetic cardiac neurons do not have pacemaker-like properties, but they do possess discharge characteristics that would enable them to closely follow excitatory synaptic activation for prolonged periods.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997322     DOI: 10.1152/ajpheart.1996.271.6.H2609

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

Review 1.  Respiratory modulation of premotor cardiac vagal neurons in the brainstem.

Authors:  Olga Dergacheva; Kathleen J Griffioen; Robert A Neff; David Mendelowitz
Journal:  Respir Physiol Neurobiol       Date:  2010-05-07       Impact factor: 1.931

2.  Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

Review 3.  Parasympathetic Vagal Control of Cardiac Function.

Authors:  Jhansi Dyavanapalli; Olga Dergacheva; Xin Wang; David Mendelowitz
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

4.  Differential control of central cardiorespiratory interactions by hypercapnia and the effect of prenatal nicotine.

Authors:  Zheng-Gui Huang; Kathleen J S Griffioen; Xin Wang; Olga Dergacheva; Harriet Kamendi; Christopher Gorini; Euguenia Bouairi; David Mendelowitz
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 5.  The polyvagal perspective.

Authors:  Stephen W Porges
Journal:  Biol Psychol       Date:  2006-10-16       Impact factor: 3.251

6.  Developmental changes in GABAergic neurotransmission to presympathetic and cardiac parasympathetic neurons in the brainstem.

Authors:  Olga Dergacheva; Carie R Boychuk; David Mendelowitz
Journal:  J Neurophysiol       Date:  2013-05-08       Impact factor: 2.714

7.  Microinjections of alpha-melanocyte stimulating hormone into the nucleus ambiguus of the rat elicit vagally mediated bradycardia.

Authors:  Vineet C Chitravanshi; Suresh Bhatt; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

Review 8.  Cardiorespiratory coupling in health and disease.

Authors:  Alfredo J Garcia; Jenna E Koschnitzky; Tatiana Dashevskiy; Jan-Marino Ramirez
Journal:  Auton Neurosci       Date:  2013-03-13       Impact factor: 3.145

9.  Quantitative pharmacokinetic-pharmacodynamic modelling of baclofen-mediated cardiovascular effects using BP and heart rate in rats.

Authors:  Harriet Kamendi; Herbert Barthlow; David Lengel; Marie-Eve Beaudoin; Debra Snow; Jerome T Mettetal; Russell A Bialecki
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

Review 10.  Innervation of the heart: An invisible grid within a black box.

Authors:  Suraj Kapa; Christopher V DeSimone; Samuel J Asirvatham
Journal:  Trends Cardiovasc Med       Date:  2015-07-09       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.